All treatments
Treatment
Fycompa 2 mg film-coated tablets clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 2 mg film-coated tablets versus reference product Fycompa 2 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions.
This study checks if a new Perampanel tablet works the same way as the existing Fycompa tablet. Healthy adults take both medicines to see if they deliver the same amount of medicine into the body. This is important to ensure new medicines are just as effective.
For: N.A. (submitted trial is a bioequivalence study in healthy human subjects)Czechia - AuthorisedTherapeutic exploratory (Phase II)
A Multicentric, Drug-Repositioning, Self Controlled Case Series (SCCS) Clinical Trial to Evaluate the Efficacy and Safety of Perampanel in Improving Behavioral Symptoms and Increasing the Quality of Life in Patients with White-Sutton syndrome (POGZ-Related Disorder)
Researchers are looking into how a medicine called perampanel might help adults with White-Sutton syndrome. It aims to see if it can improve their behaviour and quality of life over 6 to 18 months. This study will check if the medicine is safe and effective.
For: White-Sutton syndrome (POGZ-Related Disorder)Italy